论文部分内容阅读
已批准七价肺炎球菌结合疫苗(7vPn)以基于DTP儿童疫苗相同的免疫方案进行初免和加强免疫,此项多中心研究评估了7vPn与六价3组份无细胞百日咳疫苗DTP-乙型肝炎疫苗-脊髓灰质炎灭活疫苗-b型流感杆菌疫苗(DTPa-HBV-IPV/Hib)联合接种的免疫原性和安全性。将受试婴儿随机分为DTPa-HB
The seven-valent pneumococcal conjugate vaccine (7vPn) has been approved as a prime and booster immunization based on the same immunization schedule as the DTP childhood vaccine. This multicenter study evaluated the efficacy of 7vPn versus the hexavalent 3-component acellular pertussis vaccine DTP-Hepatitis B Immunogenicity and safety of the vaccine-poliomyelitis inactivated vaccine-b-type influenza bacilli vaccine (DTPa-HBV-IPV / Hib) inoculation. The infants were randomly assigned to DTPa-HB